Search
for
Sort by
Research 511–540 of 1000+
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- The role of lymphocytes in the development and treatment of alopecia areata
- Lipid nanocarriers as innovative strategies for hair regrowth
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Dermatologia Capilar: Fisiologia do Folículo Piloso e Principais Afecções
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- New treatment modalities of alopecia areata
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Hair loss and its management in children
- The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances
- Epidemiology and burden of alopecia areata in Taiwan: a systematic review
- Brief Treatment Modalities of Alopecia Areata: Review Article
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- Alopecia areata
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Progeria (Hutchinson-Gilford Syndrome): Literature Review and Clinical Case
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- Life threatening macrophage activation syndrome as the initial presentation of systemic lupus erythematosus: A case report and review of the literature
- Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors and baricitinib: A case report and literature review